Drugs
Title
Date Published
Reversal of low-molecular-weight heparin-induced bleeding in patients with pre-existing hypercoagulable states with human recombinant activated factor VII concentrate.
July 5, 2006
Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
June 30, 2006
The Risk Associated with Aprotinin in Cardiac Surgery
June 30, 2006
Recombinant Factor VII (Activated) for Haemorrhagic Complications of Severe Sepsis Treated with Recombinant Protein C (Activated).
June 30, 2006
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.
June 20, 2006
Intraoperative use of recombinant activated factor VII (rFVIIa).
June 1, 2006
Use of recombinant activated factor VII to control bleeding in a young child with qualitative platelet disorder: a case report.
June 1, 2006
Pharmacological approaches to reducing blood loss and transfusions in the surgical patient.
June 1, 2006
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.
June 1, 2006
A case of Glanzmann’s thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug.
June 1, 2006
Antiplatelet agents and perioperative bleeding.
June 1, 2006
Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage.
May 17, 2006
Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery?
May 3, 2006
Small-dose recombinant activated factor VII (NovoSeven) in cardiac surgery.
May 1, 2006
Successful Treatment of Gastrointestinal Bleeding With Recombinant Factor VIIa After Kidney Transplantation in Patients With Pancytopenia.
May 1, 2006
Effects of Half-dose Aprotinin in Off-pump Coronary Artery Bypass Grafting.
April 27, 2006
Recombinant Factor VIIa for Refractory Bleeding After Cardiac Surgery Secondary to Anticoagulation with the Direct Thrombin Inhibitor Lepirudin.
April 3, 2006
Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
April 1, 2006
Successful Treatment of Life-threatening Bleeding after Cesarean Section with Recombinant Activated Factor VII.
April 1, 2006
Traumatic hemoptysis treated with recombinant human factor VIIa.
April 1, 2006